CA2192813A1 - Methods of inducing gene expression by ionizing radiation - Google Patents

Methods of inducing gene expression by ionizing radiation

Info

Publication number
CA2192813A1
CA2192813A1 CA002192813A CA2192813A CA2192813A1 CA 2192813 A1 CA2192813 A1 CA 2192813A1 CA 002192813 A CA002192813 A CA 002192813A CA 2192813 A CA2192813 A CA 2192813A CA 2192813 A1 CA2192813 A1 CA 2192813A1
Authority
CA
Canada
Prior art keywords
ionizing radiation
methods
gene expression
inducing gene
radiation
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
CA002192813A
Other languages
French (fr)
Other versions
CA2192813C (en
Inventor
Tsuneya Ohno
Ralph R. Weichselbaum
Donald W. Kufe
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
University of Chicago
Dana Farber Cancer Institute Inc
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US08/241,863 external-priority patent/US5571797A/en
Application filed by Individual filed Critical Individual
Publication of CA2192813A1 publication Critical patent/CA2192813A1/en
Application granted granted Critical
Publication of CA2192813C publication Critical patent/CA2192813C/en
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/21—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Pseudomonadaceae (F)
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4702—Regulators; Modulating activity
    • C07K14/4705—Regulators; Modulating activity stimulating, promoting or activating activity
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • C07K14/525—Tumour necrosis factor [TNF]
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/82—Translation products from oncogenes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/67—General methods for enhancing the expression
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/0004—Oxidoreductases (1.)
    • C12N9/0089—Oxidoreductases (1.) acting on superoxide as acceptor (1.15)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Biophysics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Wood Science & Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • Medicinal Chemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Microbiology (AREA)
  • Toxicology (AREA)
  • Physics & Mathematics (AREA)
  • Plant Pathology (AREA)
  • Oncology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

The present invention provides a method for delivering ionizing radiation to specific tissues, resulting in the activation of a DNA
molecule comprising a radiation responsive enhancer-promoter operatively linked to an ecoding region that encodes at least one polypeptide.
The radiation source will generally be in the form of a radionuclide, capable of gamma or beta emissions. Processes for regulating polypeptide expression and inhibiting tumor growth using such DNA molecules are also provided.
CA002192813A 1994-05-11 1995-05-11 Methods of inducing gene expression by ionizing radiation Expired - Fee Related CA2192813C (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US08/241,863 US5571797A (en) 1994-05-11 1994-05-11 Method of inducing gene expression by ionizing radiation
US08/241,863 1994-05-11
PCT/US1995/005959 WO1995031559A2 (en) 1994-05-11 1995-05-11 Methods of inducing gene expression by ionizing radiation

Publications (2)

Publication Number Publication Date
CA2192813A1 true CA2192813A1 (en) 1995-11-23
CA2192813C CA2192813C (en) 2007-05-01

Family

ID=38051341

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002192813A Expired - Fee Related CA2192813C (en) 1994-05-11 1995-05-11 Methods of inducing gene expression by ionizing radiation

Country Status (1)

Country Link
CA (1) CA2192813C (en)

Also Published As

Publication number Publication date
CA2192813C (en) 2007-05-01

Similar Documents

Publication Publication Date Title
WO1995031559A3 (en) Methods of inducing gene expression by ionizing radiation
EP0662137B8 (en) Gene transcription and ionizing radiation: methods and compositions
MX9705039A (en) Programmed cell death genes and proteins.
ATE345682T1 (en) IN VITRO METHOD FOR INTRODUCING NUCLEIC ACIDS INTO A CELL
GR3026658T3 (en) Hydrazino-type radionuclide chelators having an n 3?s configuration
TW242147B (en)
AU5817496A (en) Process for producing erythropoietin containing no animal pr oteins
AUPN568095A0 (en) Anti-Galalpha(1,3)Gal antibody binding peptides
IL138330A0 (en) Polynucleotides, polypeptides and pharmaceutical compositions for treating lung cancer
AU4833897A (en) Glial mitogenic factors, their preparation and use
AU8783991A (en) Polypeptide,dna fragment encoding the same and process for producing the same, and enzyme inhibition process, drug composition and methods of treating using the same
IL123641A0 (en) Circular dna molecule with conditional origin of replication method for preparing the same and use thereof in gene therapy
CA2153068A1 (en) Enhancer sequence for modulating expression in epithelial cells
GR3024379T3 (en) Peptides with organo-protective activity, the process for preparing them and their use in therapy
IL118426A (en) Pharmaceutical composition containing 1,3- bis-triazolyl-2-propanol derivative for treating cancer tumors or viruses
AU1378395A (en) Metal chelators
DE69839875D1 (en) Composition containing radioisotopes immobilized on solid particles and their use in brachytherapy
HK1008347A1 (en) Dorsal tissue affecting factor and compositions
AU8040898A (en) Type-1 ribosome-inactivating protein
CA2234263A1 (en) Pharmaceutical composition for treating papillomavirus tumours and infection
CA2200855A1 (en) Radioactive phosphorous labeling of proteins for targeted radiotherapy
EP0804613A4 (en) Tumor suppressor genes, proteins encoded thereby and use of said genes and proteins
DE3576361D1 (en) RECOMBINANT DNA, TRANSFORMED MICROORGANISM, AND METHOD FOR PRODUCING HUMAN CU-ZN SUPEROXIDE DISISMUTASE USING THE TRANSFORMED MICROORGANISM.
CA2192813A1 (en) Methods of inducing gene expression by ionizing radiation
GR3027661T3 (en) Treatment of tumors with neurotrophic factors and cell proliferation inhibitors.

Legal Events

Date Code Title Description
EEER Examination request
MKLA Lapsed